As lifespan increases, neurolongevity is emerging as the critical pillar of wellness.

CORAL SPRINGS, Fla., Jan. 12, 2026 /PRNewswire/ -- Neurolief Inc., a medical device company focused on neuromodulation therapies for neuropsychiatric conditions, today announced that the U.S. Food and ...

Theranica, a neuromodulation therapeutics company advancing clinically validated, drug-free treatments for idiopathic pain conditions and setting a new standard of care in migraine with REN-based ...

Please provide your email address to receive an email when new articles are posted on . SAN FRANCISCO — Cardiac neuromodulation therapy resulted in significant reductions in systolic BP at 6 months in ...

Epilepsy is one of the most common neurological diseases, affecting around 50 million people worldwide, and carries a debilitating burden for the patient. It is characterized by recurrent seizures ...

Magnus Medical sends cease-and-desist letters to protect SAINT, an FDA-cleared breakthrough in accelerated, personalized ...

Abbott announced today that it has updated NeuroSphere, its app-driven neuromodulation therapy platform, with remote programming capabilities that will allow patients to speak with and receive ...

SANTA ANA, CA - February 09, 2026 - PRESSADVANTAGE - A newly released educational resource provides a detailed, ...

Noninvasive peripheral nerve stimulation applied repeatedly at home over a 3-month period reduced hand tremors in patients with essential tremor (ET), new research shows. In a large prospective study, ...

Spurred by the opioid crisis, a once marginalized therapy that relies on electrical stimulation to treat chronic pain is undergoing a renaissance as device makers race to upgrade their products for a ...

Study Confirms Safety of Using Theranica’s Nerivio REN Wearable for Treatment of Migraine Simultaneously with Contemporary Continuous Glucose Monitoring (CGM) Devices Published in the Journal of ...